Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ · Healthcare
Recursion Pharmaceuticals, Inc. Long Term Debt 2019–2025
Recursion Pharmaceuticals, Inc. annual long term debt history from 2021 to 2021. Long term debt refers to financial obligations that are due more than one year in the future.
- Recursion Pharmaceuticals, Inc. long term debt as of December 31, 2021: 723,000.
- Recursion Pharmaceuticals, Inc. long term debt for 2021 were 723,000.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Recursion Pharmaceuticals, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2021 | $1 |
Recursion Pharmaceuticals, Inc. Long Term Debt — FAQ
Recursion Pharmaceuticals, Inc. (RXRX) long term debt over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RXRX's long term debt history?
The chart and table above show Recursion Pharmaceuticals, Inc.'s long term debt by year and by quarter, including the growth rate.